A new government scheme in the UK came into effect on October 1st and will pay a lump sum to all mesothelioma sufferers, irrespective of occupational exposure. However, some asbestos victims are shocked and appalled to discover that some asbestosis sufferers and some mesothelioma sufferers will lose compensation in order to fund the scheme.

Alan Robinson, who suffers from asbestosis and was exposed to asbestos at Rochdale, England’s Turner & Newall factory, said: “I stand to receive about £8,000 from a T&N Fund instead of the £50,000 I should have got. The government is going to recover £4,334 and I will be left with £3,666 from the Fund. Had I concluded my claim a few months ago I would have had nearly £12,000 in compensation. That’s been cut by a third. I fully support a lump sum payment to all mesothelioma sufferers, that is a right thing to do, but it is wrong to fund the new scheme by hitting asbestos victims like me.”

The Asbestos Victims Support Groups Forum believes that government recovery is not an unintended consequence of the new Act. Chairman Tony Whitston said: "It is deliberate policy and asbestos victims and the Forum are calling on government to amend the legislation so that asbestos victims do not end up funding the new scheme.

“The government never made it clear when it received so many plaudits for introducing the new scheme that it would use compensation from some asbestosis victims and some mesothelioma sufferers who worked for T&N to fund the new scheme. We are calling on government to take immediate steps to stop funding the new scheme by reducing further small amounts of compensation received by asbestos victims.”

For more information, click here

A new study has found that up to 80 percent of cancer patients who undergo radiation treatment do not take medications to combat pain. According to the report, many of the patients cited fears of addiction as well as cost as their reasons for saying no to painkillers. However, the most common reason given was that their healthcare provider had not recommended medication. "To eliminate barriers to optimal pain management for cancer patients, healthcare providers should talk with their patients about pain symptoms and pain medications,” said Dr. Charles Simone, from the National Cancer Institute (NCI) in Bethesda, Maryland.

The findings come from an Internet-based questionnaire posted on OncoLink examining analgesic use and pain control in cancer patients getting radiation treatment. Data from 106 patients were included in the analysis. 46 percent of patients reported pain related to the cancer itself, and 58 percent of subjects had pain from their treatment, the report's author’s note in the International Journal of Radiation Oncology, Biology, and Physics. The only statistically significant factor linked to non-use of painkillers was educational level. Specifically, individuals with education beyond high school were less likely to use analgesics than those with lower educational levels (11 percent vs. 36%).

To improve pain control for cancer patients undergoing radiation, Dr. Simone said that his center, the Radiation Oncology Branch of the NCI, has established an electronic system that requires healthcare providers to assess pain levels and pain medication every time they see a patient.

For more information, click here

A California couple has filed an asbestos lawsuit against 55 companies, claiming that the mesothelioma the man was diagnosed with was wrongfully caused. Arvid and May Johnson claim Arvid was diagnosed with the disease on Sept. 15, 2008.

The lawsuit claims that while Arvid worked for various companies, including the U.S. Navy, Ace Hardware and various filling stations between the years 1947-2004, he was exposed to and inhaled dangerous asbestos fibers. Moreover, the suit claims that Johnson’s exposure was foreseeable and should have been anticipated by the defendants.

Due to the asbestos exposure, the Johnson’s claim that Arvid has become disabled and disfigured, which required him to spend large amounts of money for medical, hospital, and other health services necessary to treat the disease. As a result of his mesothelioma, Arvid is experiencing great physical pain and mental agony. Furthermore, the disease hinders and prevents Arvid from pursuing employment and as a result he lost large sums of money. Lastly, May claims that she has been deprived of the support, devotion, and care of Arvid.

The couple is seeking sums in excess of $50,000, punitive and exemplary damages in excess of $100,000 and compensatory damages in excess of $50,000.

NEWTON, MA - The Law Offices of James Sokolove (LOJS), dedicated to providing equal access to the civil justice system, announced that its MesoRC website ( www.MesoRC.com) has received a prestigious WebAward from the Web Marketing Association as one of the best web sites in 2008. Joining prior winners in the Health Care Standard of Excellence category, the website scored a first ever win for a law firm in that category.

This year's competition saw more than 2,400 sites from 45 countries being judged in 96 industry categories. Entries were judged on design, copy writing, innovation, content, interactivity, navigation, and technology.

"Our firm was founded with the mission that consumer legal needs are best met by giving consumers important and timely information," said James Sokolove, founder of LOJS. "In envisioning MesoRC, we wanted to build an innovative online community that would embody that mission by allowing mesothelioma victims and their loved ones to benefit from the experiences of others and to make their voices heard as they face life altering situations."

To Read the Press Release in its entirety, Click Here

Researchers from MIT have found that cells from different people don't all react the same way when exposed to the same DNA-damaging agent. The research team from MIT's Center for Environmental Health Sciences (CEHS) and the Departments of Biological Engineering and Biology, identified a group of 48 genes that can predict how susceptible an individual is to the toxic compound, known as MNNG. This finding could help clinicians predict how patients will respond to chemotherapy.

MNNG, is a DNA-damaging compound similar to toxic chemicals found in tobacco smoke and in common chemotherapy agent. The chemical usually kills cells by inducing irreparable DNA damage. However, the researchers found a wide range of susceptibility among cells taken from healthy people. "A cell line from one person would be killed dramatically, while that from another person was resistant to exposure," said Rebecca Fry, former MIT research scientist and lead author of the paper. "It wasn't known that cell lines from different people could have such dramatic differences in responses."

"Even if everyone is exposed to exactly the same things, they would respond differently, because we're all genetically different," said Leona Samson, senior author of the paper, director of CEHS, and an American Cancer Society Research Professor. The team members found that after measuring the expression of every gene in each cell line, they could predict cell sensitivity to MNNG from the expression of just 48 specific genes, with 94 percent accuracy. Several of those 48 genes have already been linked to cancer, said Samson, but it was not known that their expression is already altered before exposure to the DNA damaging agent.

This study is specific to MNNG, but similar efforts are now underway in Samson's lab to predict individuals' responses to other toxic agents, including cisplatin, a common chemotherapy agent, and temozolomide, used to treat brain cancer.